Biggest News Aggregation in the World
๐Ÿ“ฐ Processa Pharma News

Page 3 - Processa Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Processa Pharma. Real-time updates on events, politics, business and more.

12 Health Care Stocks Moving In Thursday's After-Market Session - Blue Water Biotech (NASDAQ:BWV), Sangamo Therapeutics (NASDAQ:SGMO), Axcella Health (NASDAQ:AXLA), Processa Pharma (NASDAQ:PCSA), Biodexa Pharmaceuticals (NASDAQ:BDRX), CervoMed (NASDAQ:CRVO), MoonLake (NASDAQ:MLTX), Aravive (NASDAQ:ARAV), 23andMe Holding (NASDAQ:ME), Novo Integrated Sciences (NASDAQ:NVOS), Virpax Pharmaceuticals (NASDAQ:VRPX), Yield10 Bioscience (NASDAQ:YTEN)

Axcella Health Biodexa Pharmaceuticals Virpax Pharmaceuticals Processa Pharma Sangamo Therapeutics Novo Integrated Sciences

12 Health Care Stocks Moving In Friday's After-Market Session - Biophytis (NASDAQ:BPTS), Processa Pharma (NASDAQ:PCSA), NeuroBo Pharmaceuticals (NASDAQ:NRBO), Biote (NASDAQ:BTMD), Aytu BioPharma (NASDAQ:AYTU), Assure Hldgs (NASDAQ:IONM), T2 Biosystems (NASDAQ:TTOO), Adial Pharmaceuticals (NASDAQ:ADIL), Mainz Biomed (NASDAQ:MYNZ), OpGen (NASDAQ:OPGN), Timber Pharmaceuticals (AMEX:TMBR)

Neurobo Pharmaceuticals Mainz Biomed Processa Pharma Adial Pharmaceuticals Aytu Biopharma

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

12 Health Care Stocks Moving In Tuesday's After-Market Session - LifeMD (NASDAQ:LFMD), Vaccitech (NASDAQ:VACC), Processa Pharma (NASDAQ:PCSA), Pasithea Therapeutics (NASDAQ:KTTA), Comera Life Sciences (NASDAQ:CMRA), MoonLake (NASDAQ:MLTX), Coeptis Therapeutics (NASDAQ:COEP), SHL Telemedicine (NASDAQ:SHLT), Amneal Pharmaceuticals (NYSE:AMRX), MSP Recovery (NASDAQ:LIFW), RVL Pharmaceuticals (NASDAQ:RVLP), GRI Bio (NASDAQ:GRI)

Pasithea Therapeutics Processa Pharma Amneal Pharmaceuticals Coeptis Therapeutics

NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch

NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch KENILWORTH (NJ) (dpa-AFX) - Todays Daily Dose brings you news about Nektars collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharmas strategic financing; and vTv Therapeutics initiation of a phase 1 multiple ascending dose study of HPP737. Read on... 1. Nektar Teams Up With Merck Nektar Therapeutics (NKTR) has entered into a clinical trial collaboration and supply agreement w...
Newsoara Biopharma Albert Bourla Processa Pharma Predictive Oncology Inc Shineco Inc European Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science